- Home
- ADPT vs CODI Comparison
ADPT vs CODI Comparison
Compare ADPT & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- CODI
- Stock Information
- Founded
- ADPT 2009
- CODI 2005
- Country
- ADPT United States
- CODI United States
- Employees
- ADPT N/A
- CODI N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- CODI Home Furnishings
- Sector
- ADPT Health Care
- CODI Consumer Discretionary
- Exchange
- ADPT Nasdaq
- CODI Nasdaq
- Market Cap
- ADPT 1.1B
- CODI 1.3B
- IPO Year
- ADPT 2019
- CODI 2006
- Fundamental
- Price
- ADPT $9.03
- CODI $6.96
- Analyst Decision
- ADPT Buy
- CODI Buy
- Analyst Count
- ADPT 6
- CODI 2
- Target Price
- ADPT $9.83
- CODI $26.00
- AVG Volume (30 Days)
- ADPT 3.0M
- CODI 1.2M
- Earning Date
- ADPT 05-01-2025
- CODI 05-20-2025
- Dividend Yield
- ADPT N/A
- CODI 14.40%
- EPS Growth
- ADPT N/A
- CODI N/A
- EPS
- ADPT N/A
- CODI N/A
- Revenue
- ADPT $189,527,000.00
- CODI $2,198,233,000.00
- Revenue This Year
- ADPT $21.20
- CODI $14.59
- Revenue Next Year
- ADPT $21.99
- CODI $7.90
- P/E Ratio
- ADPT N/A
- CODI N/A
- Revenue Growth
- ADPT 8.61
- CODI 11.87
- 52 Week Low
- ADPT $2.99
- CODI $6.05
- 52 Week High
- ADPT $10.28
- CODI $24.59
- Technical
- Relative Strength Index (RSI)
- ADPT 57.82
- CODI 15.44
- Support Level
- ADPT $8.38
- CODI $6.05
- Resistance Level
- ADPT $9.51
- CODI $17.46
- Average True Range (ATR)
- ADPT 0.66
- CODI 0.62
- MACD
- ADPT 0.16
- CODI -0.91
- Stochastic Oscillator
- ADPT 63.02
- CODI 7.79
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.